ValueBuddies.com : Value Investing Forum - Singapore, Hong Kong, U.S.

Pages (765): « Previous 1 … 753 754 755 756 757 … 765 Next »

Date & Time	Title
Sun, 02 Jun 2024 08:00:00 +0800	Innovent Presents Phase 1 Clinical Data of First-in-class PD-1/IL-2α Bispecific Antibody Fusion Protein (IBI363) in Melanoma, Colorectal Cancer and other Solid Tumors at the 2024 ASCO Annual Meeting
Sun, 02 Jun 2024 08:00:00 +0800	Innovent Presents at the 2024 ASCO Annual Meeting on Clinical Data of anti-CLDN18.2 ADC (IBI343) in Patients with Advanced Pancreatic Cancer or Biliary Tract Cancer
Sun, 02 Jun 2024 07:13:00 +0800	GenFleet Therapeutics Announces Efficacy & Safety Result from Phase II Trial for First-line NSCLC Treatment in KROCUS Study, fulzerasib (KRAS G12C Inhibitor) in Combination with cetuximab, in a Late-breaking Abstract at the Oral Presentation of 2024 ASCO Annual Meeting
Sun, 02 Jun 2024 03:00:00 +0800	Immunofoco Biotech to Unveil Solid Tumor CAR-T Programs Clinical Trial Data at 2024 ASCO Meeting
Sat, 01 Jun 2024 23:40:00 +0800	Z Grills Announces Unprecedented "Buy 1, Get 10 Grills" Promotion, Unlocking a Lifetime of Easier Grilling!
Sat, 01 Jun 2024 23:00:00 +0800	ICECO Launches APL35 on Indiegogo - The World's Lightest Aluminum Dual-Zone Freezer
Sat, 01 Jun 2024 20:00:00 +0800	TiumBio Presents Phase 1b Interim Results for TU2218 in Combination with Pembrolizumab at ASCO 2024 Annual Meeting
Sat, 01 Jun 2024 20:00:00 +0800	Immunocan Launches Innovative Alpaca-derived Nanobody Discovery Platform: ImmuAlpaca® Mouse
Sat, 01 Jun 2024 19:10:00 +0800	Ivonescimab in Combination with Chemotherapy Approved in China by NMPA for 2L+ EGFRm NSCLC based on HARMONi-A Clinical Trial: Positive Trend Observed in Overall Survival towards Ivonescimab Plus Chemotherapy
Sat, 01 Jun 2024 19:00:00 +0800	Duke-NUS' largest graduating cohort celebrates diverse pathways to medicine
Sat, 01 Jun 2024 17:55:00 +0800	ZEEKR Announces May 2024 Delivery Update
Sat, 01 Jun 2024 10:00:00 +0800	Skymizer Launches Groundbreaking LLM Accelerator IP for on-device LLM Inferencing, EdgeThought, the game-changer in on-device GenAI era.
Sat, 01 Jun 2024 10:00:00 +0800	BLUETTI EP760 Achieves CEC Approval, Enhancing Its Appeal in Australia
Sat, 01 Jun 2024 10:00:00 +0800	Gold Pecker Leads the Way: First Expert Advisor to Offer 'PAMM by Gold Pecker' for Gold Traders
Sat, 01 Jun 2024 09:14:00 +0800	KED INVESTOR ALERT: Kaskela Law LLC Announces Investigation of Keypath Education International, Inc. (ASX: KED) and Encourages Investors to Contact the Firm
Sat, 01 Jun 2024 04:30:00 +0800	TAL Education Group Files Its Annual Report on Form 20-F
Sat, 01 Jun 2024 04:30:00 +0800	China Jo-Jo Drugstores Announces Changes to Board of Directors
Sat, 01 Jun 2024 04:00:00 +0800	MingZhu Logistics Agrees to Acquire Oxylus Global; Company Targeting Continued Aggressive Diversification and Growth Acceleration Strategy
Sat, 01 Jun 2024 00:37:00 +0800	Hard Rock International Reignites "LOVE OUT LOUD" Pride Month 2024 Celebration with Special Events, Hotel Suites, Music Experiences, Cocktails and Merch
Sat, 01 Jun 2024 00:00:00 +0800	State Grid Shandong Yucheng Power Supply Company: supporting Green, Low Carbon, and High Quality Development to Reach a New Speed

Pages (765): « Previous 1 … 753 754 755 756 757 … 765 Next »

Login
Username:
Password:	Lost Password?
	Remember me